Clinical Trials for Immunophotonics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Immunophotonics

Clinical Trials (3)

NCT06630624
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
PHASE1/PHASE2Recruiting
120 participants
Started: Jul 10, 2024 · Completed: Aug 1, 2031
3 conditions3 sponsors1 location
NCT05688280
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Nov 29, 2022 · Completed: Feb 28, 2025
4 conditions1 sponsor16 locations
NCT03993678
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
PHASE1/PHASE2Active, not recruiting
28 participants
Started: Oct 12, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations